相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Advances in metformin-based metabolic therapy for non-small cell lung cancer
Na Chen et al.
ONCOLOGY REPORTS (2022)
Metformin impairs cisplatin resistance effects in A549 lung cancer cells through mTOR signaling and other metabolic pathways
Ana Paula Morelli et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice
Nicole L. Stott Bond et al.
BIOMEDICINES (2021)
Metformin-induced chemosensitization to cisplatin depends on P53 status and is inhibited by Jarid1b overexpression in non-small cell lung cancer cells
Tharcisio Citrangulo Tortelli Jr. et al.
Aging-US (2021)
Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
Nini Cao et al.
FRONTIERS IN PHARMACOLOGY (2020)
Notch Transduction in Non-Small Cell Lung Cancer
Amnah Sharif et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy
Salomon Tendler et al.
PLOS ONE (2020)
Is REDD1 a metabolic double agent? Lessons from physiology and pathology
Florian A. Britto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
Unraveling the Regulation of Hepatic Gluconeogenesis
Xueping Zhang et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein
Maryam Abbastabar et al.
DNA REPAIR (2018)
Rethinking Gamma-secretase Inhibitors for Treatment of Non-small-Cell Lung Cancer: Is Notch the Target?
Sharon R. Pine
CLINICAL CANCER RESEARCH (2018)
Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways
Shoeb Ikhlas et al.
LIFE SCIENCES (2017)
Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways
Andre Sarmento-Cabral et al.
MOLECULAR CANCER RESEARCH (2017)
Phosphorylation of AMPK by upstream kinases is required for activity in mammalian cells
Robin Willows et al.
BIOCHEMICAL JOURNAL (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus
Bin Yang et al.
ANTI-CANCER DRUGS (2017)
Metformin targets multiple signaling pathways in cancer
Yong Lei et al.
CHINESE JOURNAL OF CANCER (2017)
Targeting CDK4/6 in patients with cancer
Erika Hamilton et al.
CANCER TREATMENT REVIEWS (2016)
Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy
Ryan J. O. Dowling et al.
CELL METABOLISM (2016)
HES1 in immunity and cancer
Aradhana Rani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase
Qianqian Guo et al.
MOLECULAR MEDICINE REPORTS (2016)
Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning
Haruko Irie et al.
ONCOLOGY LETTERS (2016)
Metformin blocks progression of obesity-activated thyroid cancer in a mouse model
Jeongwon Park et al.
ONCOTARGET (2016)
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
Ernst Lengyel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling
Xiang-Lin Tan et al.
PANCREAS (2015)
Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect
Yoshifumi Saisho
ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2015)
Ki67 is a promising molecular target in the diagnosis of cancer
Lian Tao Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Metformin Inhibits Skin Tumor Promotion in Overweight and Obese Mice
L. Allyson Checkley et al.
CANCER PREVENTION RESEARCH (2014)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells
Eveline A. I. F. Queiroz et al.
PLOS ONE (2014)
Metformin Enhances Cisplatin Cytotoxicity by Suppressing Signal Transducer and Activator of Transcription-3 Activity Independently of the Liver Kinase B1-AMP-Activated Protein Kinase Pathway
Chien-Chung Lin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Metformin inhibits lung cancer cells proliferation through repressing microRNA-222
Yuqi Wang et al.
BIOTECHNOLOGY LETTERS (2013)
Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
Emelie Karnevi et al.
BMC CANCER (2013)
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
Y. Storozhuk et al.
BRITISH JOURNAL OF CANCER (2013)
The Notch signaling pathway as a mediator of tumor survival
Kathleen M. Capaccione et al.
CARCINOGENESIS (2013)
AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells
Chi-Wai Lee et al.
CANCER RESEARCH (2012)
Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers
Xin-Sheng Deng et al.
CELL CYCLE (2012)
The Effect of Physiological Stimuli on Sarcopenia; Impact of Notch and Wnt Signaling on Impaired Aged Skeletal Muscle Repair
Susan Tsivitse Arthur et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina et al.
MAYO CLINIC PROCEEDINGS (2012)
PI3K-PKB/Akt Pathway
Brian A. Hemmings et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Redd1 inhibits the invasiveness of non-small cell lung cancer cells
Hyeon-Ok Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis
Regan M. Memmott et al.
CANCER PREVENTION RESEARCH (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
STATs in cancer inflammation and immunity: a leading role for STAT3
Hua Yu et al.
NATURE REVIEWS CANCER (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Isabel M. Chu et al.
NATURE REVIEWS CANCER (2008)
Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning
SL Cai et al.
JOURNAL OF CELL BIOLOGY (2006)
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
J Brugarolas et al.
GENES & DEVELOPMENT (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
分享论文
